Core Programme Clusters

Health Systems Development (HSD)

Essential Drugs and Other Medicines (Traditional Medicine)>>Norms and Standards: Quality, Safety and Efficacy

 

The globalization of commerce and trade, and the merging of pharmaceutical companies have internationalized pharmaceutical production across the world. International norms and standards for medicines are thus more important than ever before. WHO’s mandate is to develop, establish and promote international standards with respect to food, biological, pharmaceutical and similar products. WHO develops international norms and standards, and assists various countries in its implementation.

WHO helps countries to: improve the effectiveness of their national medicine regulatory agencies; develop their quality assurance capacity; improve their implementation of good manufacturing practices and their capacity to inspect medicine distribution channels.

 

WHO coordinates the prequalification programme of United Nations to ensure the quality of medicines for priority diseases such as HIV/AIDS, Tuberculosis, Malaria. More information can be accessed at http://healthtech.who.int/pq/.

The WHO Country Office in collaboration with the CDSCO and other partners has undertaken various initiatives with a view to ensure good clinical practices as well as good pharmacy practices. Pharmocovigilance is also an important area of work.

*     Good Pharmacy Practice   

     

*     Clinical Trials          

 

*     Pharmacovigilance     

 

*     International Non Proprietary Names

 

 

 

 

   Health Systems Strengthening

   Health Financing & Social Protection

    Health Information

    Trade Agreements & Health

    Essential Drugs and Other Medicines (Traditional Medicine)

*      Medicine Policy

*      Financing & Supply Management

*      Norms and Standards:Safety, Efficacy & Quality

*      Selection & Rational Drug Use

     Research & Ethics

    Human Resources for Health

*      Governance & Policies for Health

*      Key Partners & Collaborators

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

| | | | | |